Ostin Technology Group Co., Ltd.
NASDAQ Capital MarketCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Tao Ling
- Full Time Employees
- 117
- Sector
- Technology
- Industry
- Hardware, Equipment & Parts
- Address
- Building 2, 101/201 Nanjing People's Republic of China 210046
- IPO Date
- Apr 27, 2022
- CIK
- 0001803407
- Website
- ostin-technology.com
- Similar Companies
- Business
- Ostin Technology Group Co., Ltd. (Nasdaq: OST) designs, develops, and manufactures thin-film transistor liquid crystal display (TFT-LCD) modules and polarizers primarily for consumer electronics, automotive displays, and commercial LCD applications; its display modules serve all-in-one computers, monitors, laptop computers, tablets, dashboards, navigation and multimedia systems, and multimedia graphics displays such as advertisements, promotions, scoreboards, and traffic signs in medical, education, business, outdoor, and cultural sectors; the company also produces polarizers for TFT-LCD and protective films for organic light emitting diode (OLED) panels, alongside all-in-one intelligent conference systems and Pintura wireless photo transmission systems. Founded in 2010 and headquartered in Nanjing, Jiangsu Province, China, Ostin operates manufacturing facilities in mainland China and sells products directly to display panel manufacturers and system integrators via e-commerce platforms, new media, and offline stores across mainland China, Hong Kong, Taiwan, and international markets. In recent developments, the company completed a $5 million registered direct offering of 41,666,667 Class A ordinary shares in July 2025 and secured $1.4 million through a private equity investment in February 2025 to support operations; it launched a wholly-owned U.S. subsidiary, Pintura.Life LLC, in San Francisco in April 2024 for North American expansion of Pintura products, initiated Amazon U.S. sales and Canton Fair participation for global outreach in 2025, showcased wireless photo transmission innovations at CES 2025, reported 39% sales growth and 114% gross profit surge for the half-year ended March 31, 2025, and obtained shareholder approval for a 1-for-25 share consolidation in July 2025 alongside prior governance updates.
OS Therapies Achieves Statistically Significant 2.5-Year Overall Survival in Phase 2b Trial of OST-HER2 in Fully Resected Pulmonary Metastatic Osteosarcoma
OS Therapies Announces the Publication of Four Articles on OST-HER2 and Osteosarcoma in Drug Discovery World
OS Therapies Reports First Quarter 2026 Financials and Provides Business Update
OS Therapies Appoints Industry Leader Dr. Craig Eagle as Chief Medical Advisor
BNP Paribas Primary New Issues:POST STAB Notice - NO STAB - CLARIANE TAP
BNP Paribas Primary New Issues:POST STAB NOTICE - NO STAB - BEFIMOO
OS Therapies Announces EMA Initiates Rolling Review of Conditional Marketing Authorization Application for OST-HER2 in the Prevention or Delay of Recurrence in Fully Resected Pulmonary Metastatic Osteosarcoma
OS Therapies Schedules OST-HER2 Pharmacodynamic Response Biomarker Conference Call on April 30, 2026 at 8:30am ET
Bronstein, Gewirtz & Grossman LLC Urges Ostin Technology Group Co., Ltd. Investors to Act: Class Action Filed Alleging Investor Harm
OSTIN DEADLINE TODAY: Bragar Eagel & Squire, P.C. Urges Ostin Technology Group Investors to Contact the Firm Before the April 17th Lead Plaintiff Deadline
OST Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Ostin Technology Group Co., Ltd. Securities Lawsuit — The Gross Law Firm
Bronstein, Gewirtz & Grossman LLC Urges Ostin Technology Group Co., Ltd. Investors to Act: Class Action Filed Alleging Investor Harm
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Ostin Technology Group Co., Ltd. of Class Action Lawsuit and Upcoming Deadlines - OST
SUEWALLST, LLP: OST FRAUD TIMELINE REVEALS 73-DAY PATH TO $950M INVESTOR WIPEOUT
OS Therapies Files New Patent Application Covering Biomarkers of the Immune Response to Listeria Monocytogenes
Bronstein, Gewirtz & Grossman LLC Urges Ostin Technology Group Co., Ltd. Investors to Act: Class Action Filed Alleging Investor Harm
OST'S $0.06 SHARES SOLD AS $9.40 WINNERS -- INVESTORS LOST 94%: LEVI & KORSINSKY, LLP
OSTIN DEADLINE FRIDAY: Bragar Eagel & Squire, P.C. Urges Ostin Technology Group Investors to Contact the Firm Before the April 17th Lead Plaintiff Deadline
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Ostin Technology Group Co., Ltd. of Class Action Lawsuit and Upcoming Deadlines – OST
Bronstein, Gewirtz & Grossman LLC Urges Ostin Technology Group Co., Ltd. Investors to Act: Class Action Filed Alleging Investor Harm